News & Updates

Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life
Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life
07 Nov 2024 byJairia Dela Cruz

For Singaporeans with psoriatic arthritis (PsA), disabling foot pain appears to signal a more severe disease activity and exert a wide impact on daily life.

Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life
07 Nov 2024
Opioid use ups healthcare use, costs in adults with PsA, AS
Opioid use ups healthcare use, costs in adults with PsA, AS
24 Oct 2024

Patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS) who use opioids end up with higher healthcare utilization and costs compared with those who do not use opioids, reports a study.

Opioid use ups healthcare use, costs in adults with PsA, AS
24 Oct 2024
DISCREET highlights apremilast potential for genital psoriasis
DISCREET highlights apremilast potential for genital psoriasis
22 Oct 2024 byAudrey Abella

Individuals with psoriasis creeping into their intimate areas may find relief from apremilast, as shown by the week-32 improvements in multiple disease parameters in the phase III DISCREET study.

DISCREET highlights apremilast potential for genital psoriasis
22 Oct 2024